about
Biomaterial delivery of morphogens to mimic the natural healing cascade in boneProximal tibia osteoarticular allografts in tumor limb salvage surgery.Proximal femoral reconstructions with bone impaction grafting and metal mesh.Selection of massive bone allografts using shape-matching 3-dimensional registration.Survival of massive allografts in segmental oncological bone defect reconstructions.pHEMA-nHA encapsulation and delivery of vancomycin and rhBMP-2 enhances its role as a bone graft substitute.Knee joint transplantation combined with surgical angiogenesis in rabbits--a new experimental model.Evaluation of a biodegradable graft substitute in rabbit bone defect model.Allograft reconstruction after sarcoma resection in children younger than 10 years old.Is an impacted morselized graft in a cage an alternative for reconstructing segmental diaphyseal defects?Joint preservation after extensive curettage of knee giant cell tumors.Proximal femur allograft-prosthesis with compression plates and a short stem.Surgical options for reconstruction of the extensor mechanism of the knee after limb-sparing sarcoma surgery: an evidence-based review.Latest developments in limb-salvage surgery in osteosarcoma.Treatment of long bone defects and non-unions: from research to clinical practice.Advances in segmental endoprosthetic reconstruction for extremity tumors: a review of contemporary designs and techniques.Biomaterials for Bone Regenerative Engineering.The collagen I mimetic peptide DGEA enhances an osteogenic phenotype in mesenchymal stem cells when presented from cell-encapsulating hydrogels.Structural bone allograft fractures in oncological procedures.Living donor bone banking: processing and discarding--from procurement to therapeutic use.Comparison between Constrained and Semiconstrained Knee Allograft-Prosthesis Composite Reconstructions.Proximal humeral osteoarticular allografts: technique, pearls and pitfalls, outcomes.Surgical guides (patient-specific instruments) for pediatric tibial bone sarcoma resection and allograft reconstruction.Effect of VEGF-A165 addition on the integration of a cortical allograft in a tibial segmental defect in rabbits.Treatment of critical-sized bone defects: clinical and tissue engineering perspectives.Injectable thermosensitive alginate/β-tricalcium phosphate/aspirin hydrogels for bone augmentation.Can bone scintigraphy predict the final outcome of pasteurized autografts?The character of gene expression of human periosteum used to form new tissue in allograft bone.Prevascularization promotes endogenous cell-mediated angiogenesis by upregulating the expression of fibrinogen and connective tissue growth factor in tissue-engineered bone grafts.Vascularization converts the lineage fate of bone mesenchymal stem cells to endothelial cells in tissue-engineered bone grafts by modulating FGF2-RhoA/ROCK signaling
P2860
Q26996479-98957102-9515-4673-9685-6A60A889B8D7Q33785511-D9EDA1B4-5523-4431-B480-C4D34A1D9FF9Q33838635-7FE504DB-4E19-4E90-A14E-790D90D69558Q33954182-C709F565-905D-4D77-92B7-D58190C60F4EQ33989692-53D3B42C-1821-4153-80B7-98410152C9F6Q34446441-6263928F-7BFE-4AFA-8360-B38DCE75258AQ35876132-F22338DB-846D-474A-8024-AD86E8FEFDA4Q36038934-C60DA481-225A-41FD-99D0-3F29EBBAA6B6Q36975858-565F51E2-3184-4787-9D19-C221DEFBF031Q37082837-91F1321C-7764-4DF8-B292-4F706C74BB46Q37380219-9EE99DDA-78E2-418F-8150-DEFD958AF504Q37483414-DED44DAF-EA80-4B76-849B-F18F4A983A73Q37778317-F4B1B5C5-A236-42C4-BB2F-B014647F3CA5Q37845830-7734837A-EC55-4741-B759-5E198E6D6045Q37875807-11EB6659-A440-4211-9F55-4541BA45BD96Q37888457-AF7633D1-394C-46D6-B118-FB579AD3F585Q38407687-ACC120AE-6093-4040-8C09-418A954D418FQ40962663-44E5D6C4-FAF8-40AF-B33F-4143BD3B411BQ41018248-820AA3F4-93DD-44EE-9BE1-875AA2F7FA49Q41152008-7509758A-BBE3-4A7C-9BC0-6BD366A0BC5BQ41670815-55139C33-5AC3-4F05-AAC9-6E4C8E78A934Q42093719-5B630716-FACD-4645-81A5-9A14957D4194Q43223770-6D69E9F9-BBBE-4D80-8383-9C42739F6560Q44516459-10C34602-A5D0-4FBB-854D-98ED2AC900A6Q47401003-2CE2D0C4-0201-4ABB-A1C2-36C47A082944Q47694973-A3FA8880-9C6A-4F69-8887-683B03722E3DQ53064858-1B910420-B30E-454E-8351-B9B8D4E985D4Q53464612-C46A1EFF-A269-4C34-BC15-14F68AF0002EQ55518594-9473382C-73E4-4A26-B5D8-4323615CA6D3Q58712507-4561AF90-D705-447E-8678-2AB1DF10BA81
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Massive allograft use in orthopedic oncology.
@ast
Massive allograft use in orthopedic oncology.
@en
type
label
Massive allograft use in orthopedic oncology.
@ast
Massive allograft use in orthopedic oncology.
@en
prefLabel
Massive allograft use in orthopedic oncology.
@ast
Massive allograft use in orthopedic oncology.
@en
P1476
Massive allograft use in orthopedic oncology
@en
P2093
D Luis Muscolo
Luis A Aponte-Tinao
P356
10.1016/J.OCL.2005.08.003
P577
2006-01-01T00:00:00Z